These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 32356420

  • 21. Comparison of Fecal Calprotectin Methods for Predicting Relapse of Pediatric Inflammatory Bowel Disease.
    Kittanakom S, Shajib MS, Garvie K, Turner J, Brooks D, Odeh S, Issenman R, Chetty VT, Macri J, Khan WI.
    Can J Gastroenterol Hepatol; 2017; 2017():1450970. PubMed ID: 28491862
    [Abstract] [Full Text] [Related]

  • 22. A combination of fecal calprotectin and human beta-defensin 2 facilitates diagnosis and monitoring of inflammatory bowel disease.
    Gacesa R, Vich Vila A, Collij V, Mujagic Z, Kurilshikov A, Voskuil MD, Festen EAM, Wijmenga C, Jonkers DMAE, Dijkstra G, Fu J, Zhernakova A, Imhann F, Weersma RK.
    Gut Microbes; 2021; 13(1):1943288. PubMed ID: 34313538
    [Abstract] [Full Text] [Related]

  • 23. Defining Faecal Calprotectin Thresholds as a Surrogate for Endoscopic and Histological Disease Activity in Ulcerative Colitis-a Prospective Analysis.
    Walsh A, Kormilitzin A, Hinds C, Sexton V, Brain O, Keshav S, Uhlig H, Geddes J, Goodwin G, Peters M, Collins G, Travis S.
    J Crohns Colitis; 2019 Mar 30; 13(4):424-430. PubMed ID: 30445625
    [Abstract] [Full Text] [Related]

  • 24. Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children.
    Olafsdottir E, Aksnes L, Fluge G, Berstad A.
    Acta Paediatr; 2002 Mar 30; 91(1):45-50. PubMed ID: 11883817
    [Abstract] [Full Text] [Related]

  • 25. [Fecal calprotectin as a biomarker to distinguish between organic and functional gastrointestinal disease].
    Bonnín Tomàs A, Vila Vidal M, Rosell Camps A.
    Rev Esp Enferm Dig; 2007 Dec 30; 99(12):689-93. PubMed ID: 18290691
    [Abstract] [Full Text] [Related]

  • 26. [Faecal calprotectin is a useful biomarker for intestinal inflammation].
    Theede K, Kiszka-Kanowitz M, Nordgaard-Lassen I, Nielsen AM.
    Ugeskr Laeger; 2014 Sep 08; 176(37):. PubMed ID: 25294035
    [Abstract] [Full Text] [Related]

  • 27. Levels of Fecal Calprotectin Are Associated With the Severity of Postoperative Endoscopic Recurrence in Asymptomatic Patients With Crohn's Disease.
    Boschetti G, Laidet M, Moussata D, Stefanescu C, Roblin X, Phelip G, Cotte E, Passot G, Francois Y, Drai J, Del Tedesco E, Bouhnik Y, Flourie B, Nancey S.
    Am J Gastroenterol; 2015 Jun 08; 110(6):865-72. PubMed ID: 25781366
    [Abstract] [Full Text] [Related]

  • 28. Fecal calprotectin as a biomarker of microscopic bowel inflammation in patients with spondyloarthritis.
    Campos JF, Resende GG, Barbosa AJA, de Carvalho SC, Lage JA, Cunha PFS, de Souza SCS, Ferrari MLA.
    Int J Rheum Dis; 2022 Sep 08; 25(9):1078-1086. PubMed ID: 35855677
    [Abstract] [Full Text] [Related]

  • 29. Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study.
    Manz M, Burri E, Rothen C, Tchanguizi N, Niederberger C, Rossi L, Beglinger C, Lehmann FS.
    BMC Gastroenterol; 2012 Jan 10; 12():5. PubMed ID: 22233279
    [Abstract] [Full Text] [Related]

  • 30. Fecal calprotectin: its scope and utility in the management of inflammatory bowel disease.
    Ikhtaire S, Shajib MS, Reinisch W, Khan WI.
    J Gastroenterol; 2016 May 10; 51(5):434-46. PubMed ID: 26897740
    [Abstract] [Full Text] [Related]

  • 31. Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms.
    Fagerberg UL, Lööf L, Myrdal U, Hansson LO, Finkel Y.
    J Pediatr Gastroenterol Nutr; 2005 Apr 10; 40(4):450-5. PubMed ID: 15795593
    [Abstract] [Full Text] [Related]

  • 32. Accuracies of serum and fecal S100 proteins (calprotectin and calgranulin C) to predict the response to TNF antagonists in patients with Crohn's disease.
    Boschetti G, Garnero P, Moussata D, Cuerq C, Préaudat C, Duclaux-Loras R, Mialon A, Drai J, Flourié B, Nancey S.
    Inflamm Bowel Dis; 2015 Feb 10; 21(2):331-6. PubMed ID: 25625487
    [Abstract] [Full Text] [Related]

  • 33. Faecal calprotectin in inflammatory bowel diseases: a review focused on meta-analyses and routine usage limitations.
    Laserna-Mendieta EJ, Lucendo AJ.
    Clin Chem Lab Med; 2019 Aug 27; 57(9):1295-1307. PubMed ID: 30785706
    [Abstract] [Full Text] [Related]

  • 34. Clinical utility of the assessment of fecal calprotectin in Leśniowski-Crohn's disease.
    Eder P, Stawczyk-Eder K, Krela-Kaźmierczak I, Linke K.
    Pol Arch Med Wewn; 2008 Nov 27; 118(11):622-6. PubMed ID: 19140565
    [Abstract] [Full Text] [Related]

  • 35. A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS.
    Menees SB, Powell C, Kurlander J, Goel A, Chey WD.
    Am J Gastroenterol; 2015 Mar 27; 110(3):444-54. PubMed ID: 25732419
    [Abstract] [Full Text] [Related]

  • 36. Faecal calprotectin, an useful marker in discriminating between inflammatory bowel disease and functional gastrointestinal disorders.
    Lozoya Angulo ME, de Las Heras Gómez I, Martinez Villanueva M, Noguera Velasco JA, Avilés Plaza F.
    Gastroenterol Hepatol; 2017 Mar 27; 40(3):125-131. PubMed ID: 27260632
    [Abstract] [Full Text] [Related]

  • 37. [Fecal calprotectin in differential diagnosis of irritable bowel syndrome].
    Li XG, Lu YM, Gu F, Yang XL.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Jun 18; 38(3):310-3. PubMed ID: 16778979
    [Abstract] [Full Text] [Related]

  • 38. Usefulness of Testing for Fecal Calprotectin in Pediatric Gastroenterology Clinical Practice.
    Lężyk-Ciemniak E, Tworkiewicz M, Wilczyńska D, Szaflarska-Popławska A, Krogulska A.
    Med Princ Pract; 2021 Jun 18; 30(4):311-319. PubMed ID: 33120396
    [Abstract] [Full Text] [Related]

  • 39. Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis.
    Lee SH, Kim MJ, Chang K, Song EM, Hwang SW, Park SH, Yang DH, Kim KJ, Byeon JS, Myung SJ, Yang SK, Ye BD.
    BMC Gastroenterol; 2017 Oct 23; 17(1):110. PubMed ID: 29061121
    [Abstract] [Full Text] [Related]

  • 40. High faecal calprotectin levels in intestinal tuberculosis are associated with granulomas in intestinal biopsies.
    Larsson G, Shenoy KT, Ramasubramanian R, Thayumanavan L, Balakumaran LK, Bjune GA, Moum BA.
    Infect Dis (Lond); 2015 Mar 23; 47(3):137-43. PubMed ID: 25522183
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.